Position paper of the National Osteoporosis Foundation of South Africa (NOFSA) on the use of parathyroid hormone (PTH 1–34) in the treatment of osteoporosis

Article

Position paper of the National Osteoporosis Foundation of South Africa (NOFSA) on the use of parathyroid hormone (PTH 1–34) in the treatment of osteoporosis

DOI: 10.1080/22201009.2005.10872115
Author(s): Stephen Hough National Osteoporosis Foundation, , Brynne Ascott-Evans National Osteoporosis Foundation, , Tobie de Villiers National Osteoporosis Foundation, , Jan de Weerd National Osteoporosis Foundation, , Graham Ellis National Osteoporosis Foundation, , Stan Lipschitz National Osteoporosis Foundation,

Abstract

There is no abstract available for this article, however you may find a scanned version of the first page here .

Get new issue alerts for Journal of Endocrinology, Metabolism and Diabetes of South Africa